Soyoko Morimoto
The University of Osaka(JP)
Publications by Year
Research Areas
Renal and related cancers, Immunotherapy and Immune Responses, CAR-T cell therapy research, Pancreatic and Hepatic Oncology Research, Extracellular vesicles in disease
Most-Cited Works
- → The activated conformation of integrin β7 is a novel multiple myeloma–specific target for CAR T cell therapy(2017)142 cited
- → Wilms Tumor Gene (WT1) Peptide–based Cancer Vaccine Combined With Gemcitabine for Patients With Advanced Pancreatic Cancer(2014)95 cited
- → Combination Gemcitabine and WT1 Peptide Vaccination Improves Progression-Free Survival in Advanced Pancreatic Ductal Adenocarcinoma: A Phase II Randomized Study(2018)70 cited
- → Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease(2011)65 cited
- → Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide(2016)63 cited
- → A phase I clinical study of a cocktail vaccine of Wilms’ tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma(2018)52 cited
- → Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response(2015)48 cited
- → WT1 peptide‐based immunotherapy for advanced thymic epithelial malignancies(2018)39 cited
- → Immune adjuvant therapy using Bacillus Calmette–Guérin cell wall skeleton (BCG-CWS) in advanced malignancies(2019)38 cited
- → Maintenance of complete remission after allogeneic stem cell transplantation in leukemia patients treated with Wilms tumor 1 peptide vaccine(2013)37 cited